A complete application in a minute
Tailored resume and cover letter, ready to send.
Recursion is seeking a senior leader to advance clinical pharmacology and pharmacometrics for a portfolio of oncology and rare disease programs. You will lead strategy, oversee PK/PD analyses, and drive regulatory collaborations with health authorities.
You will collaborate with cross‑functional teams, design studies, and support dose selection across Phase 1–3 while advancing a rapid development agenda in a remote U.S. setting.
Your work will change lives. Including your own.
You will join an innovative and passionate clinical development team dedicated to improving the lives of patients suffering from devastating diseases. You will lead the innovative clinical pharmacology and pharmacometrics strategy and execution for a portfolio of rare disease and oncology clinical programs.
You will join the Pharmacometrics team within Recursion comprising clinical pharmacology, pharmacometrics, and translational modeling. The Pharmacometrics group sits within Recursion’s Clinical Development organization. Team members get to sit on both Discovery and Development projects and work in a seamless end‑to‑end environment at Recursion. The team collaborates closely with clinical development functions (clinical science, clinical operations, regulatory affairs, biostatistics, etc.), as well as discovery functions (DMPK, Biology, Chemistry and Translational Biomarkers).
This is a remote position based in the United States with required periodic travel.
At Recursion, we believe that every employee should be compensated fairly. Based on the skills, experience, and qualifications needed for this role, the estimated annual base salary range is:
In addition to base salary, this role is eligible for an annual bonus, equity compensation, and a comprehensive benefits package.
Recursion (NASDAQ: RXRX) is a clinical‑stage TechBio company decoding biology to radically improve lives. Recursion is advancing a portfolio of differentiated investigational medicines across its wholly owned and partnered pipeline in oncology, rare disease, neuroscience, immunology, and other therapeutic areas with significant unmet need. Enabling its mission is the Recursion OS, an AI‑native, end‑to‑end drug discovery and development platform integrating biology, chemistry, and clinical development into a unified intelligence system. Powered by proprietary multimodal data, purpose‑built AI models, and bilingual teams fluent in both science and AI, the Recursion OS is designed to translate complex science into medicines that matter — faster, better, and at scale — for patients who are waiting.
Recursion’s platform infrastructure is anchored in Salt Lake City, Utah and Milton Park, Oxfordshire, where its automated biology and chemistry laboratories generate proprietary data at industrial scale. Recursion also maintains offices in New York, Montréal, and London, three global hubs for talent and leadership at the intersection of AI and scientific innovation. Learn more at www.recursion.com, or connect on X and LinkedIn.
Recursion is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected under applicable federal, state, local, or provincial human rights legislation.
Accommodations are available on request for candidates taking part in all aspects of the selection process.